Physician profile
Edward Westerheide
NPI 1821019258
$1,740.92
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $63.04 · 2021: $1,325 · 2022: $60.41 · 2023: $114 · 2024: $13.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $106 · Education: $21.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $106.15 |
| Education | $21.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Conformis, INC. | $1,298.78 | 2021 | |
| Vericel Corporation | $84.90 | 2022-2023 | Maci |
| Stryker Corporation | $50.41 | 2019 | |
| Si-Bone, INC. | $45.22 | 2020 | |
| Medline Industries Lp | $40.08 | 2019-2021 | |
| Conmed Corporation | $38.19 | 2023 | Conmed Generators |
| Amgen INC. | $36.79 | 2019-2024 | Prolia, Evenity |
| Radius Health, INC. | $34.66 | 2019-2020 | |
| Pacira Therapeutics, INC. | $31.77 | 2019 | |
| Fidia Pharma USA INC. | $18.50 | 2023 | Triluron, Hymovis |
| Convatec INC. | $17.67 | 2022 | |
| Medtronic USA, INC. | $15.93 | 2019 | |
| Abbott Laboratories | $15.31 | 2023 | Proclaim |
| Endo Pharmaceuticals INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Westerheide listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.